A pharmaceutical composition for reducing the rate at which skin ages or for treating cancer, acne or rosacea. The composition comprises a pharmaceutically acceptable excipient in combination with 26,27-hexafluoro-1,25-dihydroxy vitamin D. The composition is preferably administered topically at a concentration of about 0.0001% weight to about 0.01% weight.
Use Of Vitamin D Analogs To Treat Conditions Related To Increased Oxidative Stress
A pharmaceutical composition for reducing the rate at which skin ages or for treating cancer, acne or rosacea. The composition comprises a pharmaceutically acceptable excipient in combination with 26, 27-hexafluoro-1,25-dihydroxy vitamin D. sub. 3. The composition is preferably administered topically at a concentration of about 0. 0001% weight to about 0. 01% weight.